Use of FDG-PET in differentiating benign from malignant compression fractures
Open Access
- 1 May 2008
- journal article
- research article
- Published by Springer Nature in Skeletal Radiology
- Vol. 37 (5) , 405-413
Abstract
Objective The objective was to evaluate the use of fluorodeoxyglucose positron emission tomography (FDG-PET) in differentiating benign from malignant compression fractures. Patients and methods In a retrospective analysis, we identified 33 patients with 43 compression fractures who underwent FDG-PET. On FDG-PET the uptake pattern was recorded qualitatively and semiquantitatively and fractures were categorized as benign or malignant. Standardized uptake values (SUV) were obtained. MRI, CT, and biopsy results as well as clinical follow-up for 1–3 years served as standards of reference. The Student’s t test was used to determine whether there was a statistically significant difference between the SUV for benign and malignant compression fractures. Results There were 14 malignant and 29 benign compression fractures, including 5 acute benign fractures. On FDG-PET, 5 benign fractures were falsely classified as malignant (false-positive). Three of these patients underwent prior treatment with bone marrow-stimulating agents. There were two false-negative results. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of FDG-PET in differentiating benign from malignant compression fractures were 86%, 83%, 84%, 71%, and 92% respectively. The difference between SUV values of benign and malignant fractures was statistically significant (1.9 ± 0.97 for benign and 3.9 ± 1.52 for malignant fractures, p < 0.001). SUV of benign acute and chronic fractures were not statistically significant. Conclusion Fluorodeoxyglucose positron emission tomography is useful in differentiating benign from malignant compression fractures. Therapy with bone marrow-stimulating agents can mimic malignant involvement.Keywords
This publication has 20 references indexed in Scilit:
- Methods and applications of diffusion imaging of vertebral bone marrowJournal of Magnetic Resonance Imaging, 2006
- Malignant and benign compression fractures: differentiation and diagnostic pitfalls on MRIClinical Radiology, 2004
- Quantitative Assessment of Diffusion Abnormalities in Benign and Malignant Vertebral Compression Fractures by Line Scan Diffusion-Weighted ImagingAmerican Journal of Roentgenology, 2003
- F-18 FDG Positron Emission Tomography and Benign FracturesClinical Nuclear Medicine, 2003
- Vertebral Metastases: Assessment with Apparent Diffusion CoefficientRadiology, 2002
- FDG-PET Findings of Vertebral Compression Fractures in Osteoporosis: Preliminary ResultsOsteoporosis International, 2002
- Acute vertebral body compression fractures: discrimination between benign and malignant causes using apparent diffusion coefficientsBritish Journal of Radiology, 2002
- FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2000
- Noninvasive grading of musculoskeletal tumors using PET.1991
- Sensitivity and specificity of MRI in detecting malignant spinal cord compression and in distinguishing malignant from benign compression fractures of vertebraeMagnetic Resonance Imaging, 1988